Tech Center 1600 • Art Units: 1632
This examiner grants 43% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17604188 | GENE THERAPY FOR TREATING OR PREVENTING VISUAL EFFECTS IN BATTEN DISEASE | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 16975987 | NANOPATTERNING FOR CONTROLLING CELL CYTOSKELETON | Final Rejection | NORTHWESTERN UNIVERSITY |
| 17928355 | CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS AND METHODS OF USE THEREOF | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 17327872 | METHOD OF PRODUCING CELL-CONTAINING CONTAINER | Final Rejection | RICOH COMPANY, LTD. |
| 17050999 | METHODS AND COMPOSITIONS TO STIMULATE RETINAL REGENERATION | Non-Final OA | UNIVERSITY OF WASHINGTON |
| 17189967 | TDP-43 IN DEGENERATIVE DISEASE | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 16500352 | ENGINEERED CELLS EXPRESSING PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) OR A MODIFIED FORM THEREOF AND RELATED METHODS | Final Rejection | The Johns Hopkins University |
| 16707681 | PRE-SHAPED ALLOGRAFT IMPLANT FOR RECONSTRUCTIVE SURGICAL USE AND METHODS OF MANUFACTURE AND USE | Final Rejection | Allosource |
| 18042040 | PROCESS SYSTEM FOR BIOREACTOR-BASED CLEAN MEAT PRODUCTION | Non-Final OA | Merck Patent GmbH |
| 17434686 | THREE-DIMENSIONAL TISSUE CONSTRUCT AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CELL-CONTAINING COMPOSITION | Non-Final OA | The University of Osaka |
| 18421142 | COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS | Non-Final OA | ASTRAZENECA AB |
| 18023289 | COMPOSITIONS AND METHODS FOR GENERATING HUMAN YOLK SAC-LIKE HEMATOPOIETIC CELLS | Non-Final OA | UNIVERSITY HEALTH NETWORK |
| 16632332 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES | Final Rejection | THE GENERAL HOSPITAL CORPORATION |
| 17273684 | USE OF MESENCHYMAL STROMAL CELL EXOSOMES IN ANTENATAL THERAPY | Non-Final OA | Children's Medical Center Corporation |
| 17923055 | COMPOSITIONS AND METHODS FOR PROMOTING PROLIFERATION IN CARDIOMYOCYTES | Non-Final OA | THE TRUSTEES OF INDIANA UNIVERSITY |
| 18057026 | Methods for Printing Functional Human Neural Tissue | Final Rejection | Wisconsin Alumni Research Foundation |
| 17545416 | METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES | Final Rejection | Wisconsin Alumni Research Foundation |
| 17923431 | METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS | Non-Final OA | PLURI BIOTECH LTD. |
| 17781265 | COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY | Final Rejection | Cornell University |
| 17437004 | GEOMETRIC INDUCTION OF PLURIPOTENCY | Non-Final OA | CONSIGLIO NAZIONALE DELLE RICERCHE |
| 17045256 | COMPOSITIONS AND METHODS OF TREATMENT OF VISION LOSS THROUGH GENERATION OF ROD PHOTORECEPTORS FROM MÜLLER GLIAL CELLS | Final Rejection | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| 17474178 | VITRO ASSAY FOR DRUG DISCOVERY OF VALVULAR HEART DISEASE | Non-Final OA | UNIVERSITY OF SOUTH CAROLINA |
| 18220689 | CELLULAR-ANTIMICROBIAL COMBINATION COMPOSITION AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS OF JOINTS AND SOFT TISSUES | Non-Final OA | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION |
| 17119484 | DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS | Final Rejection | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION |
| 17572618 | CHIMERIC RECEPTOR THERAPY | Final Rejection | PRECIGEN, INC. |
| 18268134 | DOPAMINERGIC NEURON PROGENITOR CELLS OR CELL DERIVATIVES THEREOF OBTAINED FROM LINEAGE RESTRICTED PLURIPOTENT STEM CELLS | Non-Final OA | Aarhus Universitet |
| 18252714 | ECTOPIC CELLULAR GROWTH FACTOR EXPRESSION FOR LOW-COST PRODUCTION OF CELL-CULTURED FOODS | Non-Final OA | Trustees of Tufts College |
| 18212339 | METHOD FOR THREE-DIMENSIONAL CELL CULTURE USING CELL GROWTH PROMOTING COLLOID AND MASS PRODUCTION OF HIGH-CONCENTRATION EXTRACELLULAR COMPOSITION USING THE SAME | Non-Final OA | 3D GLOBAL BIOTECH INC. |
| 18565003 | METHODS FOR PRIMING ALLOGENEIC CULTURED KERATINOCYTE COMPOSITIONS FOR TOPICAL USE | Non-Final OA | Stratatech Corporation |
| 18297581 | PLATELETS LOADED WITH ANTI-CANCER AGENTS | Non-Final OA | Cellphire, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy